Three Frontier Labs, Three IPO Moves: What the Race to Public Markets Means for Investors and Enterprise Teams

Thirty days. Three labs. Three different moves toward public markets.

On May 20, OpenAI named Goldman Sachs and Morgan Stanley as lead underwriters for its IPO process, the clearest signal yet that its September window target is real, not aspirational. Then, on June 1, Anthropic reportedly submitted a confidential Form S-1 to the SEC, launching its own formal review process days after closing a $65 billion Series H. And through SpaceX’s financial disclosures, xAI’s quarterly economics became partially visible, a $2.47 billion operating loss against $818 million in revenue, as covered in prior hub analysis.

Three companies. Three different stages of IPO readiness. And if you’re an institutional investor, an enterprise procurement lead, or a compliance officer with Anthropic or OpenAI dependencies, those three data points tell a story that a single filing can’t.

Section 1: What Anthropic’s Filing Does and Doesn’t Confirm

The confidential S-1, formally a Draft Registration Statement under SEC confidential review procedures, is not a public document. Anthropic can engage with SEC comments, revise financial disclosures, and shape the prospectus before any of it becomes visible. That’s the design of the process: it exists precisely so issuers can address SEC concerns without market disruption. The clock starts now, but investors won’t see audited financials until the public S-1 drops, which must happen at least 15 days before any roadshow.

What the filing does confirm is intent. Companies don’t submit confidential S-1s speculatively. The Series H closed, the auditors are engaged, and the company has made the organizational decision to become a public reporting issuer. That’s a commitment with costs, Sarbanes-Oxley compliance infrastructure, quarterly earnings cadence, public scrutiny of every financial metric that was previously disclosed only to select investors.

The financial context, drawn from prior hub reporting, anchors the story. Anthropic’s annualized run-rate revenue reportedly reached $47 billion in May 2026, as previously reported, up from approximately $9 billion at the end of 2025 per the company’s own disclosures. Q2 2026 net revenue is projected at approximately $10.9 billion. Those figures, and the $36 billion gap between ARR and net revenue, will be the first thing public market analysts interrogate when the S-1 becomes readable.

Section 2: The Valuation Problem Every Public Market Investor Will Ask

The $965 billion post-money valuation is real. Reuters confirmed it independently. Lead investors, Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, negotiated that price in a private transaction with full access to Anthropic’s internal financials.

Public market investors won’t have that access until the S-1 drops. And when they do, they’ll run their own math.

At $47 billion ARR and a $965 billion valuation, Anthropic would trade at roughly 20x annualized revenue, if ARR were the right metric. It isn’t. ARR is a run-rate extrapolation, not recognized revenue. The $10.9 billion Q2 net revenue projection annualizes to approximately $43-44 billion, closer, but still structured differently from how SaaS companies report. The public market will want to understand compute costs embedded in that revenue, gross margin, and whether the growth rate ($9B to $47B ARR in five months) is sustainable or front-loaded by enterprise contract deployments.

This isn’t a reason to discount the valuation. It’s the conversation that happens in every IPO roadshow. The frontier lab premium is real, markets are pricing in leadership positions in a winner-take-most market. But the mechanics of how that premium survives the translation from private to public are genuinely unresolved, and Anthropic’s S-1 will be the first document that forces a public answer.

Section 3: The Race Map

| Lab | IPO Milestone | Reported Timeline | Key Unknown |
|—|—|—|—|
| OpenAI | Goldman Sachs + Morgan Stanley underwriters named (May 20) | Reported September 2026 window | Governance structure post-conversion from nonprofit; capped-profit mechanics |
| Anthropic | Confidential S-1 filed (June 1) | Post-SEC review; no roadshow date | ARR-to-GAAP revenue gap; compute cost disclosure |
| xAI | Financial profile partially visible via SpaceX disclosures | No public IPO move announced | Standalone entity separation from SpaceX; revenue independent of Musk platform |

The sequencing matters. OpenAI has named underwriters but hasn’t filed. Anthropic has filed but hasn’t named underwriters, at least not publicly. If Anthropic’s S-1 becomes public before OpenAI’s, Anthropic controls the first set of audited AI company financials that institutional investors will study. That’s a narrative advantage. Analysts build models from the first data they get. The second filing always gets compared to the first.

xAI is the variable. The company’s financial profile is still partially obscured by its SpaceX relationship. It hasn’t made a public IPO move. But $2.47 billion in quarterly operating losses is a number that will shape how investors think about frontier lab economics broadly, including when they evaluate Anthropic’s and OpenAI’s cost structures.

Section 4: Compliance and Enterprise Implications

Becoming a public company changes the compliance surface materially. For enterprise customers with Anthropic contracts, three areas warrant attention now rather than after the S-1 goes public.

First, customer concentration. The S-1’s risk factors section will disclose whether Anthropic’s revenue is heavily concentrated among a small number of enterprise customers. If your organization is a significant Anthropic customer, you may appear in the S-1 in ways that affect your negotiating position in future contract renewals. Legal teams should review existing agreements for any confidentiality provisions that interact with IPO disclosure requirements.

Second, material contracts. Enterprise agreements above certain revenue thresholds may require disclosure in the S-1 as material contracts. Procurement teams should anticipate that deal terms, not just the existence of a contract, could become public record.

Third, Sarbanes-Oxley and internal control obligations. Once Anthropic is a public reporting issuer, its internal controls over financial reporting will be audited. For enterprise customers running Anthropic on sensitive financial workflows, that’s a signal about governance maturity, the same controls that affect how Anthropic manages its own financial data will also govern how it handles yours.

Section 5: What Investors and Compliance Teams Should Watch

The checklist isn’t long, but the triggers are specific.

When the S-1 becomes public: Read the risk factors section first. Frontier AI companies face regulatory risk (EU AI Act, potential US AI legislation), litigation risk (training data copyright), and competitive risk (open-source alternatives and compute cost dynamics). The S-1 will price all of that in language that the company’s investor relations team negotiated with lawyers for months. That document is more candid than any earnings call.

Watch the audit committee composition. The independence and financial expertise of Anthropic’s audit committee will signal how seriously the company approached public company governance. A weak audit committee is a yellow flag on financial controls.

Watch the lock-up period and structure. The Series H investors negotiated their entry price. The lock-up structure, typically 90-180 days post-IPO, determines when and how that capital can exit. Unusual lock-up provisions (early release triggers, carve-outs for specific investors) are worth noting.

TJS synthesis

Don’t bet on Anthropic’s filing being the last piece of news before OpenAI’s S-1. The two filings are in a race that neither company controls entirely, SEC review timelines, market conditions, and underwriter readiness all matter. But Anthropic’s move to file confidentially days after the Series H close suggests leadership is treating the IPO as the primary strategic event of 2026, not an eventual outcome. The company that files first and prices cleanly sets the benchmark. Watch the week Anthropic’s S-1 goes public, the gap between its ARR figures and its GAAP revenue disclosure will be the first real test of whether frontier lab valuations survive contact with public market accountants.